These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10650450)

  • 1. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients.
    Weike AI; Bauer U; Hamm AO
    Biol Psychiatry; 2000 Jan; 47(1):61-70. PubMed ID: 10650450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol.
    Duncan E; Szilagyi S; Schwartz M; Kunzova A; Negi S; Efferen T; Peselow E; Chakravorty S; Stephanides M; Harmon J; Bugarski-Kirola D; Gonzenbach S; Rotrosen J
    Psychiatry Res; 2003 Aug; 120(1):1-12. PubMed ID: 14500109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients.
    Csomor PA; Yee BK; Feldon J; Theodoridou A; Studerus E; Vollenweider FX
    Schizophr Bull; 2009 Jan; 35(1):244-55. PubMed ID: 18245063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients.
    Braff DL; Swerdlow NR; Geyer MA
    Am J Psychiatry; 1999 Apr; 156(4):596-602. PubMed ID: 10200740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission.
    Perry W; Feifel D; Minassian A; Bhattacharjie I; Braff DL
    Am J Psychiatry; 2002 Aug; 159(8):1375-81. PubMed ID: 12153831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics do not reverse prepulse inhibition deficits in acutely psychotic schizophrenia.
    Xue YY; Wang HN; Xue F; Tan QR
    J Int Med Res; 2012; 40(4):1467-75. PubMed ID: 22971498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication.
    Kumari V; Soni W; Mathew VM; Sharma T
    Arch Gen Psychiatry; 2000 Jun; 57(6):609-14. PubMed ID: 10839340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues.
    Hamm AO; Weike AI; Schupp HT
    Psychopharmacology (Berl); 2001 Jul; 156(2-3):259-65. PubMed ID: 11549227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the clinical and cognitive meaning of impaired sensorimotor gating in schizophrenia.
    Dawson ME; Schell AM; Hazlett EA; Nuechterlein KH; Filion DL
    Psychiatry Res; 2000 Nov; 96(3):187-97. PubMed ID: 11084215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients.
    Mackeprang T; Kristiansen KT; Glenthoj BY
    Biol Psychiatry; 2002 Nov; 52(9):863-73. PubMed ID: 12399139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired prepulse inhibition of acoustic startle in schizophrenia.
    Parwani A; Duncan EJ; Bartlett E; Madonick SH; Efferen TR; Rajan R; Sanfilipo M; Chappell PB; Chakravorty S; Gonzenbach S; Ko GN; Rotrosen JP
    Biol Psychiatry; 2000 Apr; 47(7):662-9. PubMed ID: 10745060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia.
    Quednow BB; Frommann I; Berning J; Kühn KU; Maier W; Wagner M
    Biol Psychiatry; 2008 Nov; 64(9):766-73. PubMed ID: 18514166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term prospective comparison of prepulse inhibition between schizophrenic patients and healthy controls.
    Preuss UW; Zimmermann J; Watzke S; Langosch J; Siafarikas N; Wong JW; Hamm A; Weike A
    Pharmacopsychiatry; 2011 May; 44(3):102-8. PubMed ID: 21432751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication status affects the relationship of symptoms to prepulse inhibition of acoustic startle in schizophrenia.
    Duncan EJ; Bollini AM; Lewison B; Keyes M; Jovanovic T; Gaytan O; Egan G; Szilagyi S; Schwartz M; Parwani A; Chakravorty S; Rotrosen J
    Psychiatry Res; 2006 Dec; 145(2-3):137-45. PubMed ID: 17070928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine normalizes sensorimotor gating deficits in patients with schizophrenia on stable medication.
    Oranje B; Glenthøj BY
    Schizophr Bull; 2013 May; 39(3):684-91. PubMed ID: 22750632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients.
    Minassian A; Feifel D; Perry W
    Schizophr Res; 2007 Jan; 89(1-3):225-31. PubMed ID: 17005374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia.
    Duncan EJ; Szilagyi S; Efferen TR; Schwartz MP; Parwani A; Chakravorty S; Madonick SH; Kunzova A; Harmon JW; Angrist B; Gonzenbach S; Rotrosen JP
    Psychopharmacology (Berl); 2003 Apr; 167(1):63-71. PubMed ID: 12632245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial.
    Wynn JK; Green MF; Sprock J; Light GA; Widmark C; Reist C; Erhart S; Marder SR; Mintz J; Braff DL
    Schizophr Res; 2007 Sep; 95(1-3):134-42. PubMed ID: 17662577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia.
    Ludewig K; Geyer MA; Vollenweider FX
    Biol Psychiatry; 2003 Jul; 54(2):121-8. PubMed ID: 12873801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR; Light GA; Cadenhead KS; Sprock J; Hsieh MH; Braff DL
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.